Page last updated: 2024-10-22

amifostine anhydrous and Carcinoma, Small Cell

amifostine anhydrous has been researched along with Carcinoma, Small Cell in 6 studies

Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.

Carcinoma, Small Cell: An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Han, HS1
Han, JY1
Yu, SY1
Pyo, HR1
Kim, HY1
Cho, KH1
Lee, DH1
Kim, HT1
Lee, JS1
Garces, YI1
Okuno, SH1
Schild, SE1
Mandrekar, SJ1
Bot, BM1
Martens, JM1
Wender, DB1
Soori, GS1
Moore, DF1
Kozelsky, TF1
Jett, JR1
Johnson, PW1
Muers, MF1
Peake, MD1
Poulter, KM1
Gurney, EM1
Napp, VV1
Hepburn, PM1
Brown, JM1
Arquette, M1
Wasserman, T1
Govindan, R1
Garfield, D1
Senzer, N1
Gillenwater, H1
Socinski, M1
Meagher, RC1
Rothman, SA1
Paul, P1
Koberna, P1
Willmer, C1
Baucco, PA1
Rubin, P1
Salazar, O1
Zagars, G1
Constine, LS1
Keys, H1
Poulter, CA1
Van Ess, JD1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Phase I-II Study of Topotecan and Paclitaxel Followed by High-Dose Thoracic Radiation Therapy With Concomitant Cisplatin/Etoposide and Amifostine in Limited-Stage Small Cell Lung Cancer[NCT00006012]Phase 1/Phase 273 participants (Actual)Interventional2001-02-28Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

5 trials available for amifostine anhydrous and Carcinoma, Small Cell

ArticleYear
Randomized phase 2 study of subcutaneous amifostine versus epoetin-alpha given 3 times weekly during concurrent chemotherapy and hyperfractionated radiotherapy for limited-disease small cell lung cancer.
    Cancer, 2008, Oct-01, Volume: 113, Issue:7

    Topics: Aged; Amifostine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma,

2008
Phase I North Central Cancer Treatment Group Trial-N9923 of escalating doses of twice-daily thoracic radiation therapy with amifostine and with alternating chemotherapy in limited stage small-cell lung cancer.
    International journal of radiation oncology, biology, physics, 2007, Mar-15, Volume: 67, Issue:4

    Topics: Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisp

2007
A randomized trial of amifostine as a cytoprotective agent in patients receiving chemotherapy for small cell lung cancer.
    British journal of cancer, 2001, Jan-05, Volume: 84, Issue:1

    Topics: Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Sma

2001
Phase II evaluation of amifostine as an esophageal mucosal protectant in the treatment of limited-stage small cell lung cancer with chemotherapy and twice-daily radiation.
    Seminars in radiation oncology, 2002, Volume: 12, Issue:1 Suppl 1

    Topics: Amifostine; Antineoplastic Agents; Carcinoma, Small Cell; Combined Modality Therapy; Dose-Response R

2002
Systemic hemibody irradiation for overt and occult metastases.
    Cancer, 1985, May-01, Volume: 55, Issue:9 Suppl

    Topics: Amifostine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; C

1985

Other Studies

1 other study available for amifostine anhydrous and Carcinoma, Small Cell

ArticleYear
Purging of small cell lung cancer cells from human bone marrow using ethiofos (WR-2721) and light-activated merocyanine 540 phototreatment.
    Cancer research, 1989, Jul-01, Volume: 49, Issue:13

    Topics: Amifostine; Bone Marrow; Carcinoma, Small Cell; Cell Survival; Hematopoiesis; Hematopoietic Stem Cel

1989